NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma.
Saved in:
| Title: | NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. |
|---|---|
| Authors: | de Dios O; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Ramírez-González MA; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Gómez-Soria I; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Segura-Collar B; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Anatomical Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Manosalva J; Advanced Microscopy Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Megías D; Advanced Microscopy Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., De Andrea CE; Department of Anatomy, Physiology and Pathology, Universidad de Navarra, Pamplona, Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Fernández-Rubio L; Division of Immunology and Immunotherapy, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarra, Spain., Hernández-Laín A; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Neuropathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Sepúlveda-Sánchez JM; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Hospital HM Sanchinarro, Centro Integral Oncologico Clara Campal, Madrid, Spain., Rodriguez-Ruiz ME; Division of Immunology and Immunotherapy, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarra, Spain.; Department of Radiation Oncology, Clinica Universidad de Navarra, Pamplona, Navarra, Spain., Pérez-Núñez Á; Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Surgery, Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain., Wainwright DA; Department of Neurological Surgery, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.; Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA., Gargini R; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain ricgargini.imas12@h12o.es psanchezg@isciii.es.; Department of Anatomical Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Sánchez-Gómez P; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain ricgargini.imas12@h12o.es psanchezg@isciii.es. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Aug 30; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
